SMITH JEFFREY T L has a total of 14 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are DELINIA INC, ELEVEN BIOTHERAPEUTICS INC and AVAXIA BIOLOGICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Smith Jeffrey T L | 14 |
#2 | Schatzman Randall | 2 |
#3 | Latham John | 2 |
#4 | Litton Mark | 2 |
#5 | Garcia-Martinez Leon F | 1 |
#6 | Latham John A | 1 |
#7 | Feldhaus Andrew L | 1 |
#8 | Litton Mark J | 1 |
#9 | Schatzman Randall C | 1 |
Publication | Filing date | Title |
---|---|---|
US2013101598A1 | Antagonists of IL-6 to prevent or treat thrombosis | |
US2012121594A1 | Anti-IL-6 antibodies for the treatment of arthritis | |
US2012189629A1 | Anti-IL-6 antibodies for the treatment of oral mucositis | |
US2011250201A1 | Antagonists of IL-6 to raise albumin and/or lower CRP | |
US2010143294A1 | Antagonists of IL-6 to prevent or treat thrombosis | |
US2010158859A1 | Methods of treating anemia using anti-IL-6 antibodies | |
US2009291089A1 | Antagonists of IL-6 to prevent or treat thrombosis | |
US2009291082A1 | Antagonists of IL-6 to raise albumin and/or lower CRP |